Durham, North Carolina (April 01, 2021) – BioResource International (BRI) announced Flemming Mahs will join their executive leadership team in the role of Chief Commercial Officer, with a focus on portfolio commercialization.
“BRI understands the importance of having a customer-centric go to market strategy. We are excited to have Flemming on board to help us deliver on that commitment and provide leadership to support our customers globally. We envision him bringing his strong background to bear and ensuring that BRI will deliver on customer expectations”” said Dr. Giles Shih, BRI’s Chief Executive Officer.
Flemming joins BRI most recently from Amlan International where he led the start up and commercialization of life-science and bacterial controlled science-based animal health portfolio. This included increasing revenue by 23 percent, implementing a continuous improvement strategy, increasing operational efficiency, and recruiting a highly skilled commercial team. Flemming previously worked for nine years with one of BRI’s key distributors, Novus International, in various global roles to help meet customers needs and realize product potential.
Flemming holds an MBA from the Washington University in St. Louis and a Bachelor’s degree from Lindenwood University.